Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 583 to 632 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
opsin 4 (melanopsin). [source:swissprot;acc:q9uhm6]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
237.28\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
252.492\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06411\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell leukemia homeobox protein 2 (homeobox protein hox-11l1) (neural crest homeobox protein). [source:swissprot;acc:o43763]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell leukemia homeobox protein 1 (homeobox protein hox-11) (tcl-3 proto-oncogene). [source:swissprot;acc:p31314]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hect domain containing protein 1 (fragment). [source:swissprot;acc:q9ult8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein barh-like 2. [source:swissprot;acc:q9umq3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
shwachman-bodian-diamond syndrome protein (cgi-97). [source:swissprot;acc:q9y3a5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.557\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.362\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm2 (small nuclear ribonuclear protein d homolog) (g7b) (snrnp core sm-like protein sm-x5). [source:swissprot;acc:q9y333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.215\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.546\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06371\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m1 chain (ec 1.17.4.1) (ribonucleotide reductase large chain). [source:swissprot;acc:p23921]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.215\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.279\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06333\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonuclease p protein subunit p30 (ec 3.1.26.5) (rnasep protein p30) (rnase p subunit 2). [source:swissprot;acc:p78346]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
216.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0633\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 7; sds22. [source:refseq;acc:nm\_002712]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
91.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
97.4011\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tata-binding protein-associated phosphoprotein (down-regulator of transcription 1) (dr1 protein). [source:swissprot;acc:q01658]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
232.118\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.406\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06278\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna splicing factor prp17 (hprp17) (eh-binding protein 3) (ehb3). [source:swissprot;acc:o60508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.282\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06256\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav proto-oncogene. [source:swissprot;acc:p15498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.849\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0618\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav-3 protein. [source:swissprot;acc:q9ukw4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.253\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.908\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06175\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav-2 protein. [source:swissprot;acc:p52735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.526\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.212\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0615\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rac-alpha serine/threonine kinase (ec 2.7.1.-) (rac-pk-alpha) (protein kinase b) (pkb) (c-akt). [source:swissprot;acc:p31749]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
248.463\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
234.095\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06138\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rac-gamma serine/threonine protein kinase (ec 2.7.1.-) (rac-pk-gamma) (protein kinase akt-3) (protein kinase b, gamma) (pkb gamma) (stk-2). [source:swissprot;acc:q9y243]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rac-beta serine/threonine protein kinase (ec 2.7.1.-) (rac-pk-beta) (protein kinase akt-2) (protein kinase b, beta) (pkb beta). [source:swissprot;acc:p31751]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vam6/vps39-like protein (hvam6p). [source:swissprot;acc:q96jc1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
206.274\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.792\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06069\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein 4 (map 4). [source:swissprot;acc:p27816]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lymphoid enhancer binding factor 1 (lef-1) (t cell-specific transcription factor 1-alpha) (tcf1-alpha). [source:swissprot;acc:q9uju2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
225.829\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.945\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l15. [source:swissprot;acc:p39030]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.862\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
230.978\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0602\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2b.c (h2b/c). [source:swissprot;acc:q99880]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
247.47\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
233.441\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0601\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2b.q (h2b/q) (h2b-gl105). [source:swissprot;acc:q16778]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h3.1 (h3/a) (h3/c) (h3/d) (h3/f) (h3/h) (h3/i) (h3/j) (h3/k) (h3/l). [source:swissprot;acc:p16106]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2b. [source:refseq;acc:nm\_175055]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2b.s (h2b/s). [source:swissprot;acc:p57053]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2b.d (h2b/d). [source:swissprot;acc:q99877]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h3.4 (h3t) (h3/t) (h3/g). [source:swissprot;acc:q16695]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
612\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific histone h2b; h2b histone family, member u, (testis-specific). [source:refseq;acc:nm\_170610]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone h2b.e (h2b/e). [source:swissprot;acc:q99879]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a10 (hox-1h) (hox-1.8) (pl). [source:swissprot;acc:p31260]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
214.257\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.125\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06002\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b9 (hox-2e) (hox-2.5). [source:swissprot;acc:p17482]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.132\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05999\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a9 (hox-1g). [source:swissprot;acc:p31269]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c9 (hox-3b). [source:swissprot;acc:p31274]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
202.135\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05997\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q99928]\vspace{3pt}}&\multirow{14}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
214.256\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.139\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05994\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein g1c (forkhead-related protein fkhl3) (hfk3) (fragment). [source:swissprot;acc:q14488]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.14\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin-1 receptor-associated kinase 4; interleukin-1 receptor associated kinase 4. [source:refseq;acc:nm\_016123]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.14\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
627\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylserine receptor; phosphatidylserine receptor beta. [source:refseq;acc:nm\_015167]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
628\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p14867]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.14\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
629\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p34903]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
630\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase b14 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b14) (ci-b14). [source:swissprot;acc:p56556]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
202.141\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05993\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to expressed sequence aa415817. [source:sptrembl;acc:q8n4q9]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
632\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-d9 (hox-4c) (hox-5.2). [source:swissprot;acc:p28356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.254\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.166\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05979\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/